Microbiome Medicines Could Power Up CAR-T Cell Therapies
The microbiome could pave new cancer immunotherapy inroads for European biotechs, bolstered by preclinical findings…
28/07/2021 - 5 minutes
France
Avantium and Carbios Capitalize on Growing Bioplastics Demand
As the EU phases out a wide range of single-use plastics this year, investor interest…
18/05/2021 - 5 minutes
Microbiome Therapies Threatened by Covid-19 Restrictions
Providers of microbiome therapies worldwide have been hit by pandemic restrictions on the harvest of…
01/09/2020 - 5 minutes
Update: DNA Script Raises €80M to Bring Rapid DNA Synthesis to the Lab
Update on 29/07/2020: DNA Script has increased the total raised in its Series B round…
29/07/2020 - 3 minutes
Biological Fungicide Clears Wheat of Rust Disease in European Field Trial
A fungicide derived from amoeba has proven effective at protecting wheat from rust disease and…
27/07/2020 - 2 minutes
Osivax Raises €32M to Develop Universal Coronavirus and Influenza Vaccines
Osivax, a Lyon-based biotechnology company, secured €17.5M from the European Innovation Council and €15.1M from…
08/07/2020 - 3 minutes
€10M Series A Boosts Cancer Immunotherapy Hitting Tumor Sugar Coating
The French startup Phost’in Therapeutics has raised €10.3M to take its cancer immunotherapy drug against…
22/04/2020 - 3 minutes
Novacyt Launches Two-Hour Coronavirus Test After FDA Approval
The French clinical diagnostics specialist Novacyt has announced FDA authorization for its fast and easily…
26/03/2020 - 3 minutes
DBV Technologies’ Peanut Allergy Treatment Hits FDA Setback
French biotech DBV Technologies’ bid for the US approval of a skin patch to treat…
25/03/2020 - 3 minutes
Coronavirus Delays Sensorion’s Hearing Loss Phase II Trial
The French company Sensorion has been forced to delay a phase II trial in people…
16/03/2020 - 2 minutes
Immune Marker in Blood May Predict Kidney Transplant Rejection Risk
French researchers have found that the levels of certain immune cells in the blood of…
13/03/2020 - 3 minutes
Phase III Fail for MedDay’s Multiple Sclerosis Treatment
A drug developed by the French company MedDay Pharmaceuticals has failed to treat progressive forms…
11/03/2020 - 2 minutes
